3 ASX Growth Stocks With Insider Backing That Deserve A Closer Look

Simply Wall St.06-26 02:17

With inflation, interest rates and global growth expectations all pulling markets in different directions, many investors are looking for companies where insiders have meaningful skin in the game and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2646924383?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570","is_english":true,"pubTime":"2026-06-26 02:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2646924383","market":"hk","top_or_hot":-1,"title":"3 ASX Growth Stocks With Insider Backing That Deserve A Closer Look","media":"Simply Wall St.","content":"<div>\n<p>With inflation, interest rates and global growth expectations all pulling markets in different directions, many investors are looking for companies where insiders have meaningful skin in the game and ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-asx-growth-stocks-with-insider-backing-that-deserve-a-clos\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 ASX Growth Stocks With Insider Backing That Deserve A Closer Look</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 ASX Growth Stocks With Insider Backing That Deserve A Closer Look\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-26 02:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-asx-growth-stocks-with-insider-backing-that-deserve-a-clos><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With inflation, interest rates and global growth expectations all pulling markets in different directions, many investors are looking for companies where insiders have meaningful skin in the game and ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-asx-growth-stocks-with-insider-backing-that-deserve-a-clos\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LIN.AU","symbol_name":"LINDIAN RESOURCES LTD","start_time":0,"source_url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-asx-growth-stocks-with-insider-backing-that-deserve-a-clos","article_id":"2646924383","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/2054000-choice2-main-header/1585187245570"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ipx/iperionx-shares/news/3-asx-growth-stocks-with-insider-backing-that-deserve-a-clos","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2646924383","pubTimestamp":1782411432,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"With inflation, interest rates and global growth expectations all pulling markets in different directions, many investors are looking for companies where insiders have meaningful skin in the game and analysts see room for further expansion. That is exactly what the Fast Growing Stocks With High Insider Ownership screener focuses on. It highlights businesses where management conviction and growth potential align. This combination can help you focus on stocks that are not only growing quickly,...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LIN.AU":"LINDIAN RESOURCES LTD","BK4139":"生物科技","TLX":"Telix Pharmaceuticals Ltd. (Uplisting)","BK7067":"生物科技","TLX.AU":"TELIX PHARMACEUTICALS LTD","BK7095":"多种金属与采矿","REMX":"VanEck Rare Earth and Strategic Metals ETF","BK7116":"贵重金属与矿石","IPX.AU":"IperionX Ltd"},"translate_title":"值得仔细关注的3只获得内部支持的澳大利亚证券交易所成长型股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REMX":0.71,"TLX":0.89,"LIN.AU":1,"TLX.AU":1,"IPX.AU":1},"content_text":"With inflation, interest rates and global growth expectations all pulling markets in different directions, many investors are looking for companies where insiders have meaningful skin in the game and analysts see room for further expansion. That is exactly what the Fast Growing Stocks With High Insider Ownership screener focuses on. It highlights businesses where management conviction and growth potential align. This combination can help you focus on stocks that are not only growing quickly, but also have leadership teams heavily invested alongside shareholders. In this article, you will see 3 of the strongest candidates currently standing out from this screener. AdvertisementIperionX (ASX:IPX) Overview: IperionX (ASX:IPX) is building a vertically integrated titanium and critical minerals business in the United States, combining its 100% owned Titan project in Tennessee, which hosts titanium, zircon and rare earth mineral resources, with in house production of titanium metal powders for sectors such as aerospace, defense, automotive and consumer electronics. Headquartered in Charlotte, North Carolina, the company aims to supply high performance titanium products and critical minerals into a range of industrial and high value manufacturing markets. Market Cap: A$1.30b IperionX is attracting attention because it is trying to connect one of the largest titanium and rare earth mineral resources in the U.S. with an emerging titanium manufacturing platform that already produces angular and spherical powders for high value end markets. The Titan Definitive Feasibility Study outlines a large U.S. critical minerals project with heavy rare earth exposure. Recent test results show its titanium fasteners meeting or exceeding demanding performance benchmarks. At the same time, the company is still loss making, has a short cash runway and relies on higher risk external funding, so investors need to weigh growth ambitions against financial strain and a high P/B multiple that sits well above the broader Australian Metals & Mining industry. IperionX is working to connect a large U.S. titanium and rare earth resource with its growing titanium powder platform. The real story lies in how those ambitions compare with funding pressure and valuation. Get the full picture in the 2 key rewards and 2 important warning signs (2 are major!) ASX:IPX P/B Ratio as at Jun 2026 Telix Pharmaceuticals (ASX:TLX) Overview: Telix Pharmaceuticals (ASX:TLX) develops and sells radiopharmaceutical products that help doctors locate and treat cancers, using targeted imaging agents and therapies across prostate, kidney, brain and other solid tumours in markets including the United States, Europe, China and Japan. The company combines commercial products like Illuccix and Gozellix with a broad late stage pipeline of therapeutic and diagnostic candidates. Operations: Telix generates most of its revenue from Precision Medicine at about US$621.9m, supported by Manufacturing Solutions at roughly US$245.1m and Therapeutics at about US$9.3m, with the United States contributing around US$784.9m in sales. Market Cap: A$5.32b Telix Pharmaceuticals sits at the crossroads of commercial radiopharmaceutical revenues and a sizeable late stage pipeline. This is why investors are watching it closely despite recent share price weakness and ongoing losses. The core imaging business, led by Illuccix and Gozellix, is already global. Multiple Phase 3 programs in prostate and brain cancer, plus a growing glioblastoma franchise around TLX101-Px and TLX101-Tx, create clear clinical catalysts alongside new partnerships with United Imaging and Regeneron. At the same time, rising R&D spend, manufacturing build out costs, an SEC subpoena and pricing pressure in PSMA imaging all underline that this is still a high risk story. Understanding how that trade off lines up with current valuation and analyst expectations is an important consideration for investors. Telix Pharmaceuticals looks like a radiopharma story where commercial revenue and a late stage pipeline could be pulling in different directions. See how that tension shows up in the analyst forecasts for Telix Pharmaceuticals and what might be hiding behind the current share price story. ASX:TLX Earnings & Revenue Growth as at Jun 2026 Lindian Resources (ASX:LIN) Overview: Lindian Resources (ASX:LIN) is a Perth based explorer focused on gold, bauxite and rare earth element deposits across Tanzania, Guinea, Malawi, Australia and Singapore. Its flagship Kangankunde Rare Earths project in Malawi targets materials used in high tech and clean energy supply chains. Market Cap: A$1.66b Lindian Resources is drawing interest because Kangankunde is moving toward first rare earth production, with new appointments, a Singapore sales hub and an equity raise helping to fund the build out. The business is still very early stage with minimal revenue, ongoing losses and a high P/B ratio. Forecasts for very strong revenue and earnings growth, and expectations for a return to profitability within 3 years, sit alongside shareholder dilution, reliance on higher risk external funding and a relatively inexperienced, recently refreshed board. For investors hunting high insider ownership growth stocks, Lindian offers exposure to a developing rare earths project with both significant upside potential and clear execution risk that calls for closer scrutiny of the full story. Lindian Resources is being priced as a rare earths story with serious growth expectations, yet its minimal revenue and funding needs leave big questions. Get the analyst forecasts for Lindian Resources that could reveal what the market might be missing next ASX:LIN Earnings & Revenue Growth as at Jun 2026 The three stocks here are just the starting point, with the full Fast Growing Stocks With High Insider Ownership screener surfacing 98 more companies where insider alignment and growth potential build equally compelling narratives through the Fast Growing Stocks With High Insider Ownership screener. Use Simply Wall St to identify, filter and analyze the specific catalysts, insider trends and growth stories that fit your highest conviction ideas so you can focus on the opportunities that matter most to you. Take Control of Your Investment Journey  If Telix Pharmaceuticals or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen.\n            Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates.\n            Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives.\n            By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.\n         Seeking Fresh Alternatives Before They Fly? Some stocks are building quiet momentum while most investors are looking the other way. Before these fresh ideas stop being under the radar, consider moving ahead of the crowd.  Spot strengthening balance sheets early by scanning companies in the list of solid balance sheet and fundamentals (19 results) and identify quality businesses before the market fully prices in their resilience. Explore potential income opportunities by reviewing the curated 4 dividend fortresses and focus on companies where robust payouts may be most relevant to your cash flow goals. Target potential precious metals moves by checking the hand picked 33 elite gold producer stocks and see which producers could be positioned to respond if sentiment shifts toward gold.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Telix Pharmaceuticals might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2646924383","isCrawlerRequest":true}